Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 30.70
+0.15 (0.49%)
Feb 11, 2026, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 3.05 billion as of February 11, 2026. Its market cap has increased by 2.00% in one year.
Market Cap
3.05B
Enterprise Value
2.60B
Revenue
1.96B
Ranking
n/a
PE Ratio
20.37
Stock Price
30.70
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.05B, an increase of 114.28%. That is a compound annual growth rate of 3.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.05B | 0.33% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.64B |
| Intech Biopharm | 3.57B |
| Syngen Biotech | 3.47B |
| Shine-On BioMedical | 3.43B |
| Sagittarius Life Science | 3.23B |
| 3D Global Biotech | 3.22B |
| SYN-TECH Chem. & Pharm. | 3.21B |
| GlycoNex Incorporation | 2.87B |